et al. Global cancer statistics, 2012. CA: a cancer journal for clinicians 65, 87-108, doi:10.3322/caac.21262 (2015). 3 Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United St ates. Cancer research 74, 2913 -2921, doi:10.1158/0008 -5472.CAN -14-0155 (2014). 4 Burris, H. A., 3rd et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 15, 2403 -2413 (1997). 5 Moore, M. J.